M. Higashi

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

H. Nomura, H. Ishibashi, Y. Miyagi, 2009, Journal of Gastroenterology.

Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites

S. Sakisaka, F. Hirai, Takashi Tanaka, 2022, Medicina.

Effective administration methods and dosages of interferon therapy for chronic hepatitis C.

H. Nomura, H. Tada, M. Higashi, 1996, Clinical therapeutics.

Factors contributing to ribavirin‐induced anemia

H. Nomura, S. Kashiwagi, J. Hayashi, 2004, Journal of gastroenterology and hepatology.

Efficacy of low dose long‐term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha‐fetoprotein: A pilot study

H. Nomura, Y. Kashiwagi, H. Ishibashi, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of prolonged treatment following combination with ribavirin and interferon for chronic hepatitis type C: A pilot study.

H. Nomura, S. Kashiwagi, J. Hayashi, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.